Saturday, May 25, 2024

New study reveals microplastics’ alarming journey from everyday items to human organs

The extensive reach of these particles beyond the gut and into critical body tissues, raises significant concerns particularly for the most vulnerable: Our children.

Major bandage brands in the U.S. contain PFAS, study finds

Recent testing has revealed a concerning presence of PFAS, known as 'forever chemicals,' in numerous bandage brands across the U.S., including those specifically marketed to people of color.

Latest CDC data exposes U.S. healthcare’s fatal flaw: Profit over patients

As new CDC data lays bare, the U.S. grapples with a healthcare paradox: towering costs yet shorter lifespans. Explore how America's for-profit model is failing its people, spotlighting the urgent plea for Medicare for All.

Alarming pesticide levels detected in common fruits and vegetables: A closer look at the...

Unveiling the "Dirty Dozen": Navigating pesticide risks in your favorite produce to ensure safer, healthier food choices.

US bans asbestos after decades of industrial resistance

The chlor-alkali industry, which utilizes asbestos in diaphragms for chemical synthesis, is now compelled to transition towards safer alternatives.

The great unwinding

The failing battle for health and healthcare in these all too disunited states.

Ubiquitous threat: Microplastics discovered in every human placenta sample

This revelation underscores a growing environmental crisis, highlighting the pervasive infiltration of microplastics into the most intimate aspects of human life.

Under the microscope: DOJ’s antitrust probe into UnitedHealth’s market dominance

In a landmark move, the Biden DOJ initiates an antitrust investigation into UnitedHealth, unraveling the healthcare behemoth's sprawling influence and its implications for patient care and market competition.

Florida defies CDC in measles outbreak, telling parents it’s fine to send unvaccinated kids...

The CDC reported that childhood immunization rates hit a 10-year low.

Pharma CEOs grilled by Sanders: A standoff on drug pricing

"In a fiery Senate showdown, Senator Bernie Sanders challenges Big Pharma on exorbitant U.S. drug prices, revealing the stark divide between profit margins and patient access to essential medications."